FDA and Other Testimony

Our Contributions to FDA and Other Regulatory Agencies

As part of our continual presence in Washington, DC, and around the United States, whenever appropriate IFFGD offers testimony to the U.S. Food and Drug Administration (FDA) and other regulatory agencies. Through either written or in-person statements, we share the perspective of functional gastrointestinal (GI) and motility disorder patients. We urge consideration of the patient perspective in regulatory decisions and encourage additional resources to help meet their needs.